Use of Symbols in Medical Device Labeling- FDA’s Final Rule

by | Aug 19, 2016 | Gene and Cell Therapies, Medical Devices

On June 15, 2016, the FDA issued its final rule that revised certain medical device and biological labeling regulations. The rule finalizes the FDA’s 2013 proposed rule and affects biologics, IVDs, and medical devices regulated by 21 CFR Parts 660, 801, and 809. The revision allows for the inclusion of symbols in labeling without adjacent explanatory text (referred to as “stand-alone symbols”), so long as certain requirements are met. The rule also allows the use of the symbol statements “Rx only” or “Px only” for labeling of prescription devices [1].

The overall goal of the final rule is to harmonize U.S. and international labeling requirements by permitting the use of stand-alone symbols in labelling without adjacent explanatory text [2]. This allows domestic device labels to be consistent with those used on devices marketed in Europe and other foreign markets. It also makes labels more user-friendly and has the added potential benefit of reducing the costs associated with designing and redesigning the label for a medical device being marketed in the U.S., the EU, and other foreign markets.

The final rule provides three options for the use of symbols in device labeling:

  1. No use of symbols
  2. Use of symbols with accompanying explanatory text
  3. Use of stand-alone symbols if one of the following conditions is met [2,3]:

Scenario a) The symbol is from an FDA-recognized standard and is used in accordance with that standard. A symbols glossary must also be included with the device’s packaging that has the symbols and their definitions.

  • A symbols glossary is also required for scenarios a) and b) below.

Scenario b) The symbol is taken from a standards development organization (SDO) that is not recognized by the FDA, and the symbol is used in accordance with the standard. In this case, manufacturers can judge if a symbol is likely to be read and understood by the customary users of their device, in compliance with section 502(c) of the FD&C Act.

Scenario c) The symbol is from an FDA-recognized standard but is NOT used in accordance with that standard. This is another scenario in which the manufacturer may determine if a symbol is likely to be read and understood by the customary users of their device in compliance with section 502(c) of the FD & C Act.

The following are the most significant changes to the final rule as compared to the proposed rule:

  • Manufacturers are allowed to use symbols from non-FDA recognized standards (as long as certain requirements are met-detailed above).
  • Clarification that the symbols glossary must “be included in the labeling for the device”, meaning that the glossary is either in electronic or paper form, and that the device labeling on/within the package has a prominent statement identifying the glossary’s location (e.g. manufacturer’s website).
  • Addition of FDA’s definition of a standards development organization (SDO).
  • Clarification on the required components of a symbols glossary.

The FDA believes that this new rule will provide a financial benefit to the industry. The agency estimates that the reduction in label-related costs could result in an annual savings of up to $25.5 million [1].

On the same day that this new rule was issued, the FDA updated its list of recognized standards for stand-alone symbols and published the revisions in a notice. The notice broadens the recognition of six standards while adding three new consensus standards that have additional stand-alone symbols [3,4].

Table 1-Modifications and New Entries to FDA’s list of Recognized Standards [2,5]


This Final Rule becomes effective September 13, 2016.

Examples of Device Labeling Symbols



  1. Office of the Federal Register. (2016). Use of Symbols in Labeling. Available from:
  2. U.S. Food and Drug Administration. (2016, July 25). Use of Symbols in Medical Device Labeling Final Rule [Webinar]. Retrieved from:
  3. Mullen, A. (2016). FDA Issues Final Rule Permitting Use of Symbols on Device Labeling. Retrieved from:
  4. Butschli, J. (2016). FDA Issues Final Ruling on Symbols in Device Labeling. Retrieved from:
  5. Office of the Federal Register. (2016). Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 042. Retrieved from:


Emma International

Emma International

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This